(2026). Engineering of siRNA molecules to silence SphK1 mRNA for therapeutic intervention in triple-negative breast cancer: An In Silico and In Vitro Analysis. Discover Oncology.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Engineering of SiRNA Molecules to Silence SphK1 MRNA for Therapeutic Intervention in Triple-negative Breast Cancer: An In Silico and In Vitro Analysis."
Discover Oncology 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Engineering of SiRNA Molecules to Silence SphK1 MRNA for Therapeutic Intervention in Triple-negative Breast Cancer: An In Silico and In Vitro Analysis."
Discover Oncology, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.